Nunzia Pharmaceutical (NUNZ) Price & Analysis

3 Followers

NUNZ Stock Chart & Stats

$0.02

$0.00(0.00%)

At close: Jan 21 4:00 PM EST

$0.02

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.02 - $0.02

Previous CloseN/A

Volume1.00

Average Volume (3M)0.00

Market Cap

$43.46K

Enterprise Value$140.76K

Total Cash (Recent Filing)$35.37K

Total Debt (Recent Filing)$183.34K

Price to Earnings (P/E)―

Beta108.19

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.31

Shares Outstanding434,514,600

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.10

Price to Book (P/B)-2.11K

Price to Sales (P/S)0.00

P/FCF Ratio-2.29K

Enterprise Value/Market Cap3.24

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

NUNZ FAQ

What was Nunzia Pharmaceutical’s price range in the past 12 months?

Nunzia Pharmaceutical lowest stock price was $0.02 and its highest was $0.02 in the past 12 months.

What is Nunzia Pharmaceutical’s market cap?

Nunzia Pharmaceutical’s market cap is $43.46K.

When is Nunzia Pharmaceutical’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Nunzia Pharmaceutical’s earnings last quarter?

Currently, no data Available

Is Nunzia Pharmaceutical overvalued?

According to Wall Street analysts Nunzia Pharmaceutical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Nunzia Pharmaceutical pay dividends?

Nunzia Pharmaceutical does not currently pay dividends.

What is Nunzia Pharmaceutical’s EPS estimate?

Nunzia Pharmaceutical’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nunzia Pharmaceutical have?

Nunzia Pharmaceutical has 434,514,600 shares outstanding.

What happened to Nunzia Pharmaceutical’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Nunzia Pharmaceutical?

Currently, no hedge funds are holding shares in NUNZ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Nunzia Pharmaceutical

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.